Published in Vasc Health Risk Manag on November 23, 2009
Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study. Diabetol Metab Syndr (2013) 1.07
Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus. Redox Biol (2013) 0.84
Utilization of blood glucose data in patient education. Curr Diab Rep (2013) 0.82
Reactive metabolites and antioxidant gene polymorphisms in type 2 diabetes mellitus. Indian J Hum Genet (2014) 0.79
Type 1 diabetes, cardiovascular complications and sesame ( zhī má). J Tradit Complement Med (2014) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999) 16.30
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med (2004) 10.35
Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care (2005) 9.97
Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med (2000) 7.79
Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75
Lipid screening and cardiovascular health in childhood. Pediatrics (2008) 6.62
The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry (2004) 6.53
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med (2003) 5.87
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Long-term complications of diabetes mellitus. N Engl J Med (1993) 5.36
Diabetic retinopathy. N Engl J Med (2004) 5.12
Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol (1995) 4.83
Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care (2003) 4.50
Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol (1987) 4.27
Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care (2005) 3.77
Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med (2002) 3.57
Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) (1983) 3.28
The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry (2003) 3.13
The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes (2006) 3.00
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Prognosis of diabetics with diabetes onset before the age of thirty-one. II. Factors influencing the prognosis. Diabetologia (1978) 2.90
Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia (1996) 2.53
Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab (2008) 2.52
Impact of dosage frequency on patient compliance. Diabetes Care (1997) 2.43
Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol (2006) 1.92
Epidemiology of proliferative diabetic retinopathy. Diabetes Care (1992) 1.91
Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes (2002) 1.78
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia (2004) 1.73
Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes (2001) 1.69
Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ (2006) 1.65
Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care (2004) 1.64
Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics (2005) 1.63
Smoking and metabolic control in adolescents with type 1 diabetes. J Pediatr (2008) 1.61
Molecular genetics of coronary artery disease. Curr Opin Cardiol (2005) 1.58
Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr (2004) 1.50
Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ (2006) 1.49
ABC of arterial and venous disease: vascular complications of diabetes. BMJ (2000) 1.49
Risk of retinopathy in children with type 1 diabetes mellitus before 2 years of age. Am J Ophthalmol (2005) 1.48
Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int (1999) 1.33
Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care (2001) 1.31
Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes (1997) 1.30
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation (2002) 1.29
Recognizing and treating depression in patients with diabetes. Curr Diab Rep (2004) 1.24
Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med (2002) 1.24
Type 2 diabetes in children: clinical aspects and risk factors. Horm Res (2002) 1.23
Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes. Am J Epidemiol (2007) 1.22
Effect of a pediatric practice-based smoking prevention and cessation intervention for adolescents: a randomized, controlled trial. Pediatrics (2008) 1.22
Clinical management of the NIDDM patient. Impact of the American Diabetes Association practice guidelines, 1985-1993. Endocrine Fellows Foundation Study Group. Diabetes Care (1995) 1.18
Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care (2000) 1.15
Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents. Obesity (Silver Spring) (2009) 1.14
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care (1999) 1.14
Diabetic complications. The importance of glucose control. Endocrinol Metab Clin North Am (1996) 1.11
Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes. Diabetes Care (2007) 1.05
Blood pressure and retinopathy in type I diabetes. Ophthalmology (1990) 1.03
A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens (2003) 1.02
The effect of puberty on the development of early diabetic microvascular disease in insulin-dependent diabetes. Diabetes Res Clin Pract (1987) 0.98
A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol (2002) 0.98
Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke (2003) 0.98
Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab (2009) 0.97
Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. J Pediatr (2005) 0.94
Diabetic nephropathy in children and adolescents. Pediatr Nephrol (2007) 0.92
Rapid weight gain in children soon after diagnosis of type 1 diabetes: is there room for concern? Pediatr Diabetes (2008) 0.88
Diabetic neuropathy in children and adolescents. Pediatr Diabetes (2004) 0.85
Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes. Pediatr Diabetes (2006) 0.84
Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes (2002) 0.84
Predictors of first stroke in Type 1 diabetes: The Fremantle Diabetes Study. Diabet Med (2005) 0.84
Clinical predictors of retinopathy and its progression in patients with type I diabetes during CSII or conventional insulin treatment. Diabetes (1985) 0.82
Peripheral nerve function is increasingly impaired during puberty in adolescents with type 1 diabetes. Diabetes Care (2001) 0.82
Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes. Metabolism (2002) 0.82
Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf) (1997) 0.80
Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial. Diabetes Technol Ther (2007) 0.80
Blood pressure response to standing in the diagnosis of autonomic neuropathy: the EURODIAB IDDM Complications Study. Arch Physiol Biochem (2001) 0.80
The familial clustering of renal disease and related phenotypes. Med Clin North Am (2005) 0.78
Diabetes mellitus: biological determinants of atherosclerosis and restenosis. Semin Interv Cardiol (1999) 0.78
A six-year follow-up study of smoking habits and microvascular complications in young adults with type 1 diabetes. Postgrad Med J (1997) 0.76
Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med (2012) 3.27
Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care (2013) 2.03
BMI alterations during treatment of childhood ALL-response. Pediatr Blood Cancer (2011) 1.39
Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer (2011) 1.15
Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant (2010) 1.03
Obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy. Pediatr Blood Cancer (2013) 0.86
Hypothalamic obesity in a patient with craniopharyngioma: dysregulation of neurohormonal control of energy balance. Curr Opin Pediatr (2005) 0.81
Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatr Diabetes (2014) 0.81
Glucagon-like peptide-1 agonist exendin-4 leads to reduction of weight and caloric intake in a rat model of hypothalamic obesity. Horm Res Paediatr (2012) 0.78
Screening for vitamin D insufficiency in pediatric cancer survivors. Pediatr Blood Cancer (2013) 0.77
Failure to thrive, hyponatremia, and hyperkalemia in a neonate. Pediatr Ann (2013) 0.77
Use of Commonly Available Technologies for Diabetes Information and Self-Management Among Adolescents With Type 1 Diabetes and Their Parents: A Web-Based Survey Study. Interact J Med Res (2015) 0.77
Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis. J Clin Invest (2016) 0.76
A facilitated peer mentoring program for junior faculty to promote professional development and peer networking. Acad Med (2015) 0.76
Type 1 diabetes mellitus. Pediatr Rev (2013) 0.75